PCT, a Hitachi Group Company
PCT, a Hitachi Group Company, is an industry leader in contract development and manufacture of cell therapy products. With our unprecedented exclusive cell therapy-focused experience, we help our Clients bridge the gap between discovery and patient care through efficient transfer of cell-based therapies from laboratory into clinical practice.
Our passion at PCT is the advancement of your cell therapy products. We will help to reduce the risks of product development, shorten the time it takes to receive regulatory approval, and reduce the overall costs of your clinical development program – we have the record to prove it. In fact, we’re the only contract development and manufacturing organization (CDMO) to see a Client’s cell therapy product receive marketing approval from the FDA.
Our services include
Over 14 years of exclusive cell therapy experience
Over 100 clients served.
Over 6000 patients treated
cGMP facilities in New Jersey and California
Excellent customer service
Dedicated to client success
Exclusive focus on cell therapy
Proven successful regulatory track record
Custom, on-demand services reduce overall costs
Client-driven project teams
No IP claims